Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Oral Maxillofac Pathol ; 27(3): 599, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-38033965

RESUMEN

Introduction: Tobacco and areca nuts release carcinogens, which cause alterations in saliva. Evaluation of these changes through estimation of salivary flow rate and pH was performed in tobacco and areca nut chewers and apparently healthy subjects. Material and Methods: The study group for this comparative study comprised 60 subjects with 20 areca nut chewers (group 1), 20 tobacco chewers (group 2), and 20 non-tobacco and areca nut chewers (group 3) in the ages between 18 and 75 years. After collection of saliva from each subject, the salivary flow rate (SFR) was measured by using graduated tubes, whereas salivary pH was measured using a digital salivary pH meter. Tukey HSD post hoc test was performed for comparison of mean SFR and mean pH between study group subjects. Analysis of variance (ANOVA) test was used to find the mean difference in SFR and pH in duration, intensity, and frequency among various types of areca nut and tobacco users. A "P" value of less than 0.05 was considered as statistically significant. Results: The mean age among groups 1, 2, and 3 was 37.70 ± 10.44, 39.75 ± 10.16, and 37.90 ± 10.52 years, respectively, with a statistically insignificant difference. The mean salivary flow rate (ml/20 min) was maximum in group 3 (13.23), followed by group 2 (11.75) and group 1 (10.48), with the statistically significant difference as P < 0.05. The mean salivary pH was maximum in group 3 (7.07), followed by group 2 (6.86) and group 1 (6.49), with the statistically significant difference as P < 0.05. Conclusion: Long-term use of tobacco and areca nuts in a chewable form can significantly reduce the salivary flow rate and salivary pH. Hence, these measurements can be used as chair side, non-invasive measures for assessing pathological changes in oral mucosa linked to vulnerable effects among people addicted to these adverse habits; thereby, early re-organization can prevent mobility and mortality.

2.
Asian Pac J Cancer Prev ; 22(1): 125-129, 2021 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-33507689

RESUMEN

OBJECTIVE: The current research was conducted with an aim to assess the association of oral microbiome with Potentially malignant disorders (PMDs) because usage of tobacco in any form alters the normal microbiome and shifts it towards dysbiosis. Thus, our definitive knowledge of the oral commensal bacteria and oral cancer link can definitely be used as a potential adjunct to early diagnosis and management of PMDs and prevent it's malignant transformation. STUDY DESIGN: A total of 100 individuals of minimum 18 years of age were included in the study which, were classified into 2 groups of tobacco users (50) and non-tobacco users (50). The tobacco users had a history of tobacco consumption for at least 5 years. RESULTS: The present study, showed highest percentage (72%) of anaerobic bacteria, followed by aerobic (22%) and lowest count of yeast (4%). CONCLUSION: The ecological shift to dysbiosis is a significant finding in oral carcinogenesis. Further investigation on a larger group of altered microbiomes will definitely help in establishing relationship of altered microbiome and PMDs, which can help in appropriate treatment and better prognosis.


Asunto(s)
Transformación Celular Neoplásica/patología , Disbiosis/complicaciones , Microbiota , Neoplasias de la Boca/diagnóstico , Boca/microbiología , Saliva/microbiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Disbiosis/microbiología , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Neoplasias de la Boca/epidemiología , Neoplasias de la Boca/microbiología , Neoplasias de la Boca/prevención & control , Pronóstico , Adulto Joven
3.
Indian J Gastroenterol ; 33(1): 23-30, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24006122

RESUMEN

PURPOSE: Variations in biliary anatomy are common, and different classifications have been described. These classification systems have not been compared to each other in a single cohort. We report such variations in biliary anatomy on magnetic resonance cholangiopancreatography (MRCP) using six different classification systems. METHODS: In 299 patients undergoing MRCP for various indications, biliary anatomy was classified as described by Couinaud (1957), Huang (1996), Karakas (2008), Choi (2003), Champetier (1994), and Ohkubo (2004). Correlation with direct cholangiography and vascular anatomy was done. Bile duct dimensions were measured. Cystic duct junction and pancreaticobiliary ductal junction (PBDJ) were classified. RESULTS: Normal biliary anatomy was noted in 57.8 %. The most common variants were Couinaud type D2, Choi type 3A, Huang type A1, Champetier type a, Ohkubo types D and J, and Karakas type 2a. The Ohkubo classification was the most appropriate; 3.1 % of right ducts and 6.3 % of left ducts with variant anatomy could not be classified using the Ohkubo classification. There was a good agreement between MRCP and direct cholangiography (ĸ = 0.9). Anomalous PBDJ was noted in 8.7 %. Variant biliary anatomy was not associated with gender (p = 0.194) or variant vascular anatomy (p = 0.24). CONCLUSION: Although each classification system has its merits and demerits, some anatomical variations cannot be classified using any of the previously described classifications. The Ohkubo classification system is the most applicable as it considers most clinically relevant variations pertinent to hepatobiliary surgery.


Asunto(s)
Anatomía/clasificación , Conductos Biliares/anatomía & histología , Conductos Biliares/anomalías , Pancreatocolangiografía por Resonancia Magnética , Estudios de Cohortes , Femenino , Humanos , Masculino
4.
Cardiovasc Intervent Radiol ; 36(4): 1161-4, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22996588

RESUMEN

A case of surgically created splenorenal shunt complicated with shunt myelopathy was successfully managed by placement of a stent graft within the splenic vein to close the portosystemic shunt and alleviate myelopathy. To our knowledge, this is the first report of a case of shunt myelopathy in a patient with noncirrhotic portal fibrosis without cirrhosis treated by a novel technique wherein a transjugular intrahepatic route was adopted to deploy the stent graft.


Asunto(s)
Hipertensión Portal/cirugía , Derivación Portosistémica Intrahepática Transyugular/efectos adversos , Enfermedades de la Médula Espinal/etiología , Enfermedades de la Médula Espinal/terapia , Stents , Adulto , Procedimientos Endovasculares/métodos , Estudios de Seguimiento , Humanos , Hipertensión Portal/patología , Masculino , Derivación Portosistémica Intrahepática Transyugular/métodos , Enfermedades Raras , Medición de Riesgo , Enfermedades de la Médula Espinal/patología , Tomografía Computarizada por Rayos X/métodos , Resultado del Tratamiento , Ultrasonografía Doppler de Pulso
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA